Amelioration of Cardiac Remodeling and Dysfunction by Nifedipine Gits is Correlative to the Calcineurin Activities in Serum of the Patients with Heart Failure

Jingmin Zhou,Yunzeng Zou,Aijun Sun,Shijun Wang,Ying Yu,Junbo Ge

DOI: https://doi.org/10.1016/j.yjmcc.2007.07.024

2008-01-01

Abstract:Calcium channel blocker has been shown beneficial for not only hypertensive patients with cardiac hypertrophy but also for those with heart failure. The presence of calcineurin in human serum has been found which is considered to be relative to some diseases such as diabetes and hypertrophied cardiomyopathy. We therefore investigated whether the effects of Nifedipine Gits on heart failure are associated with the levels of calcineurin activities in the serum of patients. Twenty patients who met following criteria were enrolled: (1) LVEF <40% and LVED >56 mm; (2) resting BP >130/80 mm Hg, and the BP after treatment with Nifedipine Gits >100/70 mm Hg. All the patients received Nifedipine Gits 30 mg per day for 4 weeks. The serum was collected at both the starting and end of the study, and the calcineurin activities and BNP levels in serum were measured. The LVED, LVSD and LVEF were also determined by echocardiography. The BP was lowed by 4.5±2.1 mm Hg at 2 weeks compared with baseline and remained unchanged thereafter. At 4 weeks after treatment, in patients with higher calcineurin activities, the LVED and LVSD were significantly increased, and the LVEF was lowered; whereas in patients with lower calcineurin activities, the LVED and LVSD were significantly decreased, and the LVEF was elevated. Moreover, the change of BNP levels tended to correlate with that of calcineurin activities. We conclude that the decrease of calcineurin activities in serum might predict the improvement of cardiac remodeling and dysfunction.